Intrommune Reports Positive Update from Ongoing Phase 1 Study in Peanut Allergy Press Releases / By Intrommune
Intrommune Therapeutics Names Sergi X. Trilla, MD, MBA as its Director, Corporate Strategy & Partnerships Press Releases / By Intrommune
Forsyth dentech 2021 “A Revolutionary Toothpaste Based Approach to Food Allergy Immunotherapy.” Events / By Intrommune
Intrommune Therapeutics Appoints Gerard Kugel, D.M.D., M.S., Ph.D. to its Scientific Advisory Board Press Releases / By Intrommune
Intrommune Therapeutics Appoints Moises V. “Moe” Vela, Jr. to its Business Advisory Board Press Releases / By Intrommune
InnovatorMD World Congress 2021 Food Allergy Toothpaste Mediated Oral Mucosal Immunotherapy – Landscape and Potential Events / By Intrommune
